BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP
Adastra Holdings Ltd. XTXXF
3 fiscal years on record · CAD · FY2022 reported · SEC filings only
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
CAD 13.3M
Revenue, FY2022 · full 3-year series below
Revenue CAD M
Net income CAD M
FY2022 · Revenue 13.3 · Net income -4.3
5M10M-3M-6M
202020212022
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−32 cents
lost on every revenue dollar
Operating margin
Net margin
FY2022 · Operating -6.0% · Net -32.2%
-100%-200%-300%
202020212022
ROE
FY2022 · ROE -21.1%
-20%-40%-60%
202020212022
Three returns, three denominators.
Each CAD of equity lost 21 cents this year.
The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · CAD
row low → row highnegative—not applicable◌not available in our data
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue CAD B | 0.0 | 0.0 | 0.0 |
| Operating income CAD B | −0.0 | −0.0 | −0.0 |
| EBITDA CAD B | −0.0 | −0.0 | −0.0 |
| Income tax CAD B | −0.0 | −0.0 | 0.0 |
| Net income CAD B | −0.0 | −0.0 | −0.0 |
| Free cash flow CAD B | 0.0 | −0.0 | −0.0 |
| EPS, diluted CAD | −0.07 | −0.05 | −0.19 |
| Dividend / sh CAD | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — |
| ROE % | −21.1 | −16.9 | −75.5 |
| Shares out B | 0.06 | 0.07 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Compare
This company against its peers
Adastra Holdings Ltd.vsMindWalk Holdings Corp.Same industry: Pharmaceutical PreparationsAdastra Holdings Ltd.vsMedicure Inc.Same industry: Pharmaceutical PreparationsAdastra Holdings Ltd.vsAvricore Health Inc.Same industry: Pharmaceutical PreparationsAdastra Holdings Ltd.vsOrganigram Global Inc.Same industry: Pharmaceutical PreparationsAdastra Holdings Ltd.vsPyroGenesis Canada Inc.Same industry: Pharmaceutical Preparations
Provenance
Company facts, as filed
How we verify · 0 failures in 15 reconciliationsAUDITED
Reconciled in 3 of the 3 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 13 checks were skipped: EPS is not tagged before 2020. 13 checks were skipped: revenue is not tagged before 2020.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inoutside the United States — SEC code A1
Fiscal year endsDecember 31
Data on record since2020